Clinical Trial Update: Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma [NA]

View source ↗

Summary

This clinical trial update describes a Phase II study investigating the safety and efficacy of a combined CAR-T cell therapy after autologous stem cell transpla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: The Affiliated Hospital of Xuzhou Medical University | Conditions: Multiple Myeloma (MM), Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) | NA | Status: NOT_YET_RECRUITING